Sarcoma is a group of uncommon cancers that can develop in bones or in the soft tissues of the body. Soft tissues include structures such as muscle, fat, blood vessels, nerves, tendons and connective tissues.
Unlike many other cancers, sarcomas are not one single disease. There are many different subtypes, and their behaviour, treatment and prognosis can vary considerably.
Treatment planning therefore depends on identifying the exact type of sarcoma, understanding its grade and stage, determining where it is located and assessing whether it has spread.
Sarcoma is a type of cancer that begins in connective, supportive or structural tissues. It can arise in bone or in soft tissues throughout the body. :chatgpt-content-reference{index="1"}
Soft-tissue sarcomas can develop in areas such as the arms, legs, abdomen, chest, head and neck. Bone sarcomas arise from bone and include several distinct tumour types. :chatgpt-content-reference{index="2"}
Bone sarcomas originate in bone. Different subtypes have different biological characteristics and may require different treatment strategies.
Soft-tissue sarcomas develop in tissues that support and connect different parts of the body. There are numerous recognised subtypes.
Sarcoma treatment cannot be determined by the tumour location alone. The exact pathology and biological characteristics of the tumour are important when developing a treatment plan.
Different sarcoma subtypes can behave differently and may respond differently to treatment.
The grade provides information about how abnormal the tumour cells appear and how aggressively the tumour may behave.
The size and location of the tumour and whether cancer has spread influence treatment planning.
The relationship of the tumour to nearby muscles, nerves, blood vessels and organs can affect surgical planning.
Age, general health, existing medical conditions and previous treatment can influence which therapies are suitable.
Treatment may aim for cure, long-term disease control, symptom relief or preservation of function and quality of life.
Accurate diagnosis matters. Because sarcoma includes many different tumour types, treatment decisions are generally based on the specific pathology, tumour characteristics and clinical stage rather than simply the fact that a tumour is called "sarcoma."
Depending on the type and location of sarcoma, treatment may involve more than one specialist. Surgery, radiation therapy and systemic treatments may be combined when clinically appropriate. :chatgpt-content-reference{index="3"}
A multidisciplinary approach can help integrate pathology, imaging and clinical findings before deciding on the most appropriate treatment sequence.
The symptoms of sarcoma depend on where the tumour develops and its size. Some sarcomas may initially cause few symptoms and may be discovered when a lump or abnormality is investigated.
A lump or swelling beneath the skin may be one of the first signs of a soft-tissue sarcoma. A lump that continues to grow should be medically assessed.
Sarcomas can sometimes cause pain or discomfort, particularly when a tumour presses on nearby nerves, muscles or other structures.
Swelling may occur around a tumour and can become more noticeable as the tumour increases in size.
A tumour near a joint, muscle or nerve may interfere with movement or cause stiffness in the affected area.
Bone sarcomas may cause persistent pain or tenderness in the affected bone. Pain can sometimes become more noticeable at night or with activity.
Depending on the tumour's location, symptoms may include abdominal discomfort, digestive symptoms, difficulty swallowing or pressure-related symptoms.
Most lumps are not cancerous. However, certain characteristics make it important to have a lump assessed rather than assuming that it is harmless.
A lump can have many causes, including benign cysts, infections, inflammation, lipomas and other non-cancerous conditions.
Imaging and, when appropriate, a properly planned biopsy may be needed to determine what a suspicious mass represents.
If sarcoma is suspected, biopsy planning is particularly important because the biopsy approach can influence later surgical treatment.
Bone sarcomas may present differently from soft-tissue sarcomas. Persistent bone pain or swelling should be assessed, especially when symptoms do not improve or continue to worsen.
Pain that continues over time or progressively worsens may require further investigation.
Swelling may develop around the affected bone or nearby tissues.
A tumour close to a joint can cause stiffness, restricted movement or difficulty using the affected limb.
In many people, the exact cause of sarcoma is not known. Most people diagnosed with sarcoma do not have a clearly identifiable risk factor.
Previous radiation therapy can rarely increase the risk of developing a later sarcoma.
Certain inherited conditions can increase the risk of particular sarcoma types.
A family history of certain inherited cancer syndromes may be relevant when assessing individual risk.
Some rare medical conditions may be associated with an increased risk of particular sarcomas.
Having a risk factor does not mean that a person will develop sarcoma. Conversely, sarcoma can occur in people without any known risk factors. A new or changing lump should therefore be assessed based on its clinical features rather than risk factors alone.
Early assessment of a suspicious mass can help establish the correct diagnosis and determine the appropriate next step. Patients may be referred to a specialist when imaging or examination suggests a possible sarcoma.
If you have already undergone investigations, bring relevant scan reports, imaging discs, pathology or biopsy reports and previous treatment records to the consultation.
Reviewing the available information together can help the specialist determine whether additional testing is required.
Discuss your symptoms, imaging or biopsy results with an oncology specialist and understand the next steps in your evaluation and treatment planning.
Book an Oncology ConsultationDiagnosing sarcoma usually involves a combination of clinical examination, imaging and tissue evaluation. Because sarcoma has many different subtypes, establishing an accurate diagnosis is particularly important before treatment is planned.
The diagnostic process is tailored to the location and characteristics of the suspected tumour. Imaging may help define the size and extent of a mass, while a biopsy can provide tissue for pathological examination.
The doctor evaluates the location, size, duration and characteristics of a lump or other symptoms.
Imaging helps determine the location and extent of a suspected tumour and its relationship with nearby structures.
A biopsy may be performed to obtain tissue for pathological examination and establish the tumour type.
Additional investigations may be used to determine whether the cancer has spread and to establish the stage.
Different imaging techniques provide different types of information. The choice of imaging depends on where the suspected sarcoma is located and what the medical team needs to determine.
MRI is particularly useful for evaluating soft-tissue tumours. It can help define the size and location of a mass and its relationship to muscles, nerves, blood vessels and other nearby structures.
CT can provide detailed cross-sectional images and may be used to evaluate the primary tumour or assess other areas of the body, including the chest when clinically appropriate.
X-rays can be useful when evaluating abnormalities involving bone and may provide an initial view of certain bone lesions.
In selected situations, PET-based imaging may help assess metabolic activity and look for disease elsewhere in the body. Its use depends on the specific sarcoma and clinical circumstances.
Imaging alone cannot always confirm sarcoma. A suspicious mass may have several possible causes, so imaging findings need to be interpreted together with clinical and pathological information.
When sarcoma is suspected, obtaining an appropriate tissue sample can be an important part of establishing the diagnosis. The biopsy should be planned carefully, particularly when surgery may subsequently be required.
The biopsy tract can sometimes need to be removed as part of definitive surgery. For this reason, biopsy placement and technique should be considered in the context of possible future treatment.
A suspicious mass should therefore not be repeatedly sampled or removed without an appropriate diagnostic and treatment plan.
Sarcoma pathology can be complex because there are many distinct tumour subtypes. The pathology report may provide information about the tumour type, grade and other characteristics relevant to treatment.
A pathologist examines the tumour tissue under a microscope to determine its cellular characteristics and help establish the diagnosis.
Additional laboratory tests may be used to identify proteins or markers that help distinguish one tumour type from another.
Selected sarcomas may have characteristic genetic or molecular changes. Molecular testing can sometimes help confirm the diagnosis or provide information relevant to treatment.
Because sarcoma diagnosis can be specialised, review of pathology by an experienced sarcoma pathologist may be considered when the diagnosis is uncertain or complex.
Staging describes how extensive the cancer is and helps the oncology team determine the most appropriate treatment approach. The staging system can vary depending on the sarcoma subtype and whether it arises in bone or soft tissue.
The size, depth and local extent of the primary tumour can be important factors in staging and treatment planning.
Lymph-node involvement may be assessed where relevant to the specific sarcoma type.
Investigations may be performed to determine whether cancer has spread to distant organs, commonly including the lungs for certain sarcomas.
Stage is only one part of treatment planning. The sarcoma subtype, tumour grade, anatomical location, molecular characteristics, previous treatment and the patient's overall health may all influence the recommended treatment.
Once the diagnosis and extent of disease have been established, the oncology team can discuss the treatment strategy. In some cases, several specialists need to review the case before the treatment sequence is finalised.
Depending on the type and stage of sarcoma, treatment may involve surgery, radiation therapy, chemotherapy, targeted treatment, immunotherapy or a combination of approaches.
The order in which treatments are given can also be important. Some patients may receive treatment before surgery, while others may undergo surgery first.
Sarcomas are broadly classified into bone sarcomas and soft-tissue sarcomas. Within these categories there are many distinct subtypes, each with different biological and clinical characteristics.
Identifying the specific subtype is important because treatment recommendations can differ significantly between sarcomas.
Bone sarcomas arise from bone and include several uncommon malignancies.
Soft-tissue sarcomas can develop in connective and supporting tissues throughout the body.
Soft-tissue sarcoma includes many different tumour types. Some of the more commonly recognised subtypes include the following.
A sarcoma showing features of fat tissue. Several distinct subtypes exist, and their behaviour and treatment can differ.
A malignant tumour arising from smooth muscle cells. It can develop in different parts of the body.
A distinct sarcoma that often occurs in the soft tissues near joints, although it can arise in other locations as well.
A high-grade soft-tissue sarcoma that can develop in various parts of the body, particularly in adults.
GIST is a specialised type of sarcoma that develops in the gastrointestinal tract and has distinct molecular and treatment characteristics.
There are numerous other sarcoma subtypes. Specialist pathological assessment can be important when the diagnosis is uncommon or complex.
Sarcoma treatment is individualised. Depending on the tumour subtype, stage, location and other clinical factors, treatment may involve surgery, radiation therapy, chemotherapy, targeted therapy, immunotherapy or a combination of approaches.
Surgery is an important treatment for many localised sarcomas. The goal may be to remove the tumour with an appropriate margin while preserving function whenever possible.
Radiation may be used before or after surgery in selected soft-tissue sarcomas or for symptom control in certain situations.
Chemotherapy may be used for selected sarcoma subtypes, particularly certain bone sarcomas and advanced or chemotherapy-sensitive soft-tissue sarcomas.
Certain sarcomas have molecular characteristics that can make targeted medicines an appropriate treatment option.
Immunotherapy may have a role in selected sarcomas or specific clinical circumstances. Its suitability depends on the tumour type and individual patient factors.
Pain management, rehabilitation, nutrition and psychological support can form an important part of comprehensive sarcoma care.
Not every patient needs every treatment. The treatment plan is selected according to the specific sarcoma subtype, grade, stage, location, molecular findings, previous treatment and overall health.
The order of treatment can be just as important as the treatments themselves. Depending on the situation, treatment may begin with surgery or with another therapy before surgery.
Pathology and imaging are reviewed to establish the exact tumour diagnosis.
Imaging and staging investigations determine the extent of disease.
Specialists determine which treatment or combination of treatments is appropriate.
Clinical assessment and appropriate imaging help evaluate response during and after treatment.
When the tumour is confined to its original location, treatment often focuses on controlling the primary tumour. Surgery is frequently an important component, with radiation or systemic therapy considered when appropriate.
When a tumour involves nearby structures or is difficult to remove safely, treatment may require careful planning and combinations of surgery, radiation or systemic therapy.
If sarcoma has spread to distant parts of the body, systemic treatment often becomes an important part of care. Selected patients may also benefit from treatment directed at individual metastatic sites.
Two people diagnosed with sarcoma may receive very different treatment plans. The tumour subtype, location, grade, stage and molecular characteristics can all influence the recommended approach.
A personalised treatment plan aims to balance effective cancer control with preservation of function, treatment tolerance and quality of life. Treatment decisions should be made after a detailed review of the patient's pathology, imaging and overall clinical condition.
Sarcoma treatment depends on the exact subtype, stage, grade, location and overall health of the patient. Treatment may involve one modality or a combination of surgery, radiation therapy and systemic treatment.
The sequence of treatment is also individualised. Some patients may receive treatment before surgery, while others may undergo surgery as the initial treatment.
Surgery is a key treatment for many localised sarcomas. The aim is generally to remove the tumour completely while preserving as much normal tissue and function as safely possible.
Radiation therapy uses high-energy radiation to damage cancer cells. It may be recommended before or after surgery for selected soft-tissue sarcomas or used for symptom control in appropriate situations.
Chemotherapy uses medicines that circulate throughout the body. Its role varies considerably between sarcoma subtypes.
Some sarcomas contain specific molecular alterations that can be targeted with medicines designed to interfere with pathways involved in tumour growth.
Molecular testing may therefore be relevant for selected sarcoma subtypes, particularly when conventional treatment options are limited.
Immunotherapy helps the immune system recognise or attack cancer cells. Its role in sarcoma is dependent on the tumour subtype and individual clinical circumstances.
It may be considered in selected advanced or specific sarcoma settings when clinically appropriate.
Supportive care can be provided throughout treatment to manage symptoms, treatment side effects and other physical or emotional needs.
Sarcoma surgery can be technically complex because the tumour may lie close to important muscles, nerves, blood vessels or organs. Surgical planning therefore considers both cancer control and preservation of function.
Removal of a large tumour may leave a significant tissue defect. Depending on the location, reconstructive surgery may be considered to restore structure and function.
The reconstructive plan may be discussed as part of the overall surgical strategy rather than as a separate decision.
Limb-sparing surgery may be possible for many patients. The appropriate surgical approach depends on tumour location, involvement of nearby structures, response to other treatments and whether the tumour can be removed safely with an adequate margin.
Radiation therapy is not required for every patient with sarcoma. When it is recommended, the timing and dose depend on the tumour characteristics and the treatment objective.
Pre-operative radiation may be considered in selected soft-tissue sarcomas to help control the local disease before surgical removal.
Post-operative radiation may be recommended when there is a significant risk of local recurrence or other clinical indications.
Radiation may also be used to control symptoms or treat selected sites of disease when curative surgery is not possible.
When sarcoma has spread beyond the original site, treatment may require medicines that work throughout the body. The choice of systemic therapy depends strongly on the sarcoma subtype and previous treatments.
In advanced sarcoma, treatment may aim to control tumour growth, reduce symptoms, preserve function, delay progression and maintain quality of life.
In selected situations, local treatment of metastatic sites may also be considered alongside systemic therapy.
Because sarcoma treatment can involve several different disciplines, treatment planning may involve surgeons, medical oncologists, radiation oncologists, radiologists, pathologists and rehabilitation specialists.
Evaluates whether the tumour can be removed safely and plans the appropriate surgical approach.
Assesses the role of chemotherapy, targeted therapy, immunotherapy and other systemic treatments.
Determines whether radiation may improve local tumour control or help manage symptoms.
Accurate interpretation of pathology and imaging helps guide diagnosis, staging and treatment decisions.
Discuss your diagnosis, pathology reports and imaging findings with an oncology specialist to understand the treatment options that may be appropriate for your specific sarcoma.
Book an Oncology ConsultationSarcoma treatment is not based on a single standard approach. Because sarcoma includes many different tumour types, treatment planning needs to consider the individual characteristics of both the cancer and the patient.
A personalised approach brings together pathology, imaging, staging, tumour biology and the patient's overall health to determine which treatments are most appropriate.
The exact sarcoma subtype can influence which treatments are likely to be effective and which therapies may not be appropriate.
The location of the tumour and its relationship to nearby structures can influence surgery, radiation planning and functional outcomes.
Tumour grade provides information about how the cancer cells appear and can contribute to assessing the behaviour of the disease.
The presence or absence of spread to other parts of the body can substantially change the treatment strategy.
In selected sarcomas, molecular findings may help refine the diagnosis or identify potentially relevant targeted treatment options.
Age, general health, organ function, previous treatment, functional needs and personal preferences may all be considered.
Treatment decisions are made by bringing together information from several parts of the diagnostic and clinical evaluation.
Sarcoma cases can require input from multiple medical specialities. A multidisciplinary approach allows the diagnosis, imaging and treatment options to be reviewed together before the treatment sequence is finalised.
Assesses whether the tumour can be removed and considers the safest surgical approach while aiming to preserve function.
Evaluates chemotherapy, targeted therapy, immunotherapy and other systemic treatment options.
Determines whether radiation may be useful before or after surgery or for selected advanced disease situations.
Examines tumour tissue and helps establish the exact sarcoma subtype and relevant pathological characteristics.
Interprets imaging to help define tumour extent, anatomy and response to treatment.
Physiotherapy and rehabilitation can support mobility, strength, function and recovery during or after treatment.
Some sarcomas have characteristic molecular changes that can help distinguish one subtype from another. In selected situations, molecular testing can therefore contribute to diagnosis and treatment planning.
No. The need for molecular testing depends on the specific sarcoma subtype, pathology findings and clinical situation.
Testing should be selected when the result is expected to provide clinically useful information rather than performed automatically for every patient.
Precision medicine does not mean using the newest treatment for every patient. It means using relevant diagnostic and molecular information to select treatment options that are appropriate for the individual tumour and clinical situation.
The goals of treatment can differ depending on whether sarcoma is localised, locally advanced or metastatic.
For localised disease, treatment may aim to remove or eradicate the cancer and reduce the risk of recurrence.
Where possible, treatment planning considers preservation of mobility, organ function and quality of life.
In metastatic disease, treatment may focus on controlling tumour growth, delaying progression and maintaining quality of life.
Because sarcoma is relatively uncommon and includes many subtypes, patients may wish to obtain another specialist opinion when the diagnosis or treatment plan is complex.
Every sarcoma case is different. A treatment approach that is appropriate for one sarcoma subtype may not be appropriate for another. Care should therefore be based on a confirmed diagnosis, appropriate staging and a treatment plan tailored to the individual patient.
Sarcoma symptoms can vary considerably depending on whether the tumour develops in soft tissue or bone and where it is located. Early sarcoma may sometimes cause few noticeable symptoms.
A new or enlarging lump, persistent pain or unexplained swelling should be assessed by a medical professional, particularly when the symptom continues or changes over time.
A lump or swelling that continues to increase in size can be one of the signs of a soft-tissue sarcoma.
Pain may occur when a tumour affects nearby tissues, nerves, muscles or bone.
A tumour may cause swelling or a feeling of fullness in the affected area.
Tumours near joints or muscles may sometimes interfere with movement or normal function.
Persistent or unexplained bone pain can occur with some bone sarcomas and should be evaluated when it does not resolve.
Depending on the location, sarcoma may cause pressure-related or organ-specific symptoms.
Most lumps are not sarcoma. However, certain features may warrant further medical assessment rather than simply observing the swelling.
Evaluation does not mean that a person has cancer. Imaging and, when appropriate, biopsy help determine the cause of a suspicious lesion.
If sarcoma is suspected, appropriate referral and diagnostic planning can help avoid unnecessary procedures and ensure that treatment is planned correctly.
Diagnosing sarcoma usually involves a combination of clinical assessment, imaging and tissue examination. The exact tests depend on the location and suspected type of tumour.
The doctor assesses the lump, pain, movement, location and other relevant symptoms.
Imaging helps determine the size, location and relationship of the tumour to surrounding structures.
Tissue is obtained and examined by a pathologist to establish the diagnosis.
Additional investigations may be performed to determine whether the disease has spread.
Imaging provides important information about the tumour before a biopsy or treatment plan is finalised.
MRI is particularly useful for evaluating soft-tissue sarcomas and defining their relationship to muscles, nerves, blood vessels and other structures.
CT may be used to evaluate the primary tumour in selected situations and to assess areas such as the chest for possible spread.
X-rays can provide useful information when a bone tumour is suspected and may form part of the initial evaluation.
Imaging can identify a suspicious tumour, but a definitive diagnosis generally requires examination of tissue under a microscope.
When sarcoma is suspected, the biopsy should be planned with the eventual treatment approach in mind. The biopsy site and technique can influence subsequent surgery.
This is one reason suspicious sarcoma lesions should be evaluated by an experienced multidisciplinary team.
A suspected sarcoma should not be treated based on imaging alone. A properly planned biopsy and specialist pathology review are important for establishing the diagnosis and guiding treatment.
Staging helps doctors understand how extensive the disease is and supports treatment planning. The staging system can vary depending on the type and location of sarcoma.
The size and local extent of the primary tumour are assessed.
The regional lymph nodes may be evaluated when clinically relevant.
Investigations may assess whether cancer has spread to distant organs.
In many sarcomas, tumour grade contributes to understanding the biological behaviour of the cancer.
Follow-up is an important part of sarcoma care because recurrence can occur even after apparently successful treatment. The follow- up schedule is individualised according to the sarcoma subtype, stage, treatment and risk of recurrence.
Follow-up appointments may include physical examination, discussion of symptoms and assessment of recovery.
Periodic imaging may be recommended to monitor the original tumour site and, where appropriate, other areas at risk.
Physiotherapy and rehabilitation may help restore mobility, strength and function after treatment.
New or changing symptoms should be reported rather than waiting until the next scheduled appointment.
Survivorship care may include monitoring for treatment-related effects and supporting long-term health and quality of life.
Follow-up intervals vary and should be determined by the treating oncology team based on individual risk factors.
If you notice a persistent or growing lump, unexplained swelling or ongoing bone or soft-tissue pain, seek medical evaluation. These symptoms can have many causes and do not necessarily mean cancer, but appropriate assessment is important when symptoms persist or progress.
Sarcoma can be a complex cancer because there are many different subtypes and treatment approaches. Care is planned around the individual diagnosis, stage, tumour characteristics and treatment goals.
Treatment recommendations are based on the specific sarcoma subtype, stage, location, pathology and overall clinical condition.
Complex sarcoma cases may require coordination between surgical oncology, medical oncology, radiation oncology, pathology and radiology.
Treatment decisions should be guided by established oncology principles, the available clinical evidence and the patient's individual circumstances.
Previous biopsy reports, pathology findings, imaging and treatment records can be reviewed when planning the next step in care.
Treatment planning considers not only cancer control but also preservation of function, recovery and quality of life where clinically possible.
Follow-up after treatment helps monitor recovery, detect recurrence when it occurs and address ongoing supportive-care needs.
Here are answers to some common questions about sarcoma diagnosis, treatment and follow-up.
Sarcoma is a group of cancers that develop from connective and supporting tissues such as bone, muscle, fat, blood vessels, nerves and other soft tissues. Sarcomas are broadly classified as bone sarcomas and soft-tissue sarcomas.
Symptoms depend on the tumour location. A growing lump, persistent swelling, unexplained pain or reduced movement can occur. Some sarcomas may cause few symptoms initially.
No. Most lumps are not sarcoma. However, a lump that is growing, persistent, deep, firm or associated with ongoing symptoms should be assessed by a healthcare professional.
Diagnosis generally involves clinical assessment, imaging and a biopsy. Tissue examination by a specialist pathologist is important for determining the specific sarcoma subtype.
In most suspected sarcomas, tissue diagnosis is important before definitive treatment. The biopsy should be planned carefully because its location and technique can affect subsequent treatment.
Surgery is an important treatment for many localised sarcomas. Depending on the subtype and stage, treatment may also involve radiation therapy, chemotherapy, targeted therapy or other systemic treatments.
Treatment depends on the specific sarcoma. Surgery is important for many localised tumours, but radiation, chemotherapy or systemic treatments may have important roles in selected situations. The appropriate approach must be determined individually.
Chemotherapy is used for selected sarcoma subtypes and clinical situations. Its role varies significantly between different types of sarcoma.
Radiation therapy may be recommended for selected soft-tissue sarcomas before or after surgery, for certain unresectable tumours or for symptom control in advanced disease.
Some sarcoma subtypes have molecular characteristics that can make targeted therapy relevant. Molecular testing may be considered when the result could help guide treatment.
When sarcoma has spread to distant organs, systemic treatment often becomes an important part of care. Depending on the individual situation, selected metastatic sites may also be treated with surgery, radiation or other local approaches.
Sarcoma treatment can involve several different specialties. Coordinating pathology, imaging, surgery, radiation and systemic treatment can help create a more comprehensive treatment strategy.
Yes. A second opinion can be useful when the sarcoma is uncommon, the diagnosis is complex, treatment options differ or the disease has returned or spread.
If available, bring your biopsy and pathology reports, immunohistochemistry or molecular reports, MRI or CT reports, imaging discs or digital images, previous treatment records and your current medication list.
Follow-up is an important part of sarcoma care. The schedule varies according to the tumour type, stage, treatment and individual risk of recurrence. Your oncology team can recommend an appropriate surveillance plan.
A sarcoma diagnosis can raise many questions about treatment, surgery, chemotherapy, radiation and long-term outcomes. The most appropriate treatment depends on the exact diagnosis rather than simply the word "sarcoma."
Understanding the pathology report, stage, tumour location and available treatment options can help patients and families make informed decisions together with their oncology team.
If you have already received a sarcoma diagnosis, keeping your pathology reports and imaging records together can help your oncology team review the diagnosis and plan the next steps efficiently.
Discuss your sarcoma diagnosis, pathology and imaging with an oncology specialist to understand your treatment options and the next steps in your care.
Book an Oncology ConsultationMedical Disclaimer: The information provided on this page is intended for general educational purposes only and should not be considered a substitute for professional medical advice, diagnosis or treatment. Sarcoma treatment varies from person to person based on the tumour subtype, stage, location, pathology, overall health and other clinical factors. Please consult a qualified oncology specialist for an individual assessment and treatment recommendations.
Precision Oncology Clinic, the best Cancer Clinic in Bangalore, located in Vijayanagar. Book appointment!
©2024. All Rights Reserved. Precision Oncology Clinic
By HAAPS
Book Appointment